Dr. Agarwal's Eye Hospital Limited (BOM:526783)

Market Cap	24.06B +20.5%
Revenue (ttm)	4.51B +19.2%
Net Income	698.50M +35.8%
EPS	147.50 +34.7%
Shares Out	4.83M
PE Ratio	33.75
Forward PE	n/a
Dividend	6.50 (0.13%)
Ex-Dividend Date	Nov 7, 2025

Volume	238
Average Volume	1,315
Open	5,024.05
Previous Close	5,023.05
Day's Range	4,952.20 - 5,042.55
52-Week Range	3,866.90 - 6,392.00
Beta	-0.57
RSI	64.96
Earnings Date	May 30, 2026

About BOM:526783

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrom...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1957
• Employees: 1,255
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526783

Financial Performance

In fiscal year 2025, BOM:526783's revenue was 3.97 billion, an increase of 24.38% compared to the previous year's 3.19 billion. Earnings were 546.50 million, an increase of 17.88%.